Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
50 hedge funds and large institutions have $38.9M invested in Kindred Biosciences, Inc. in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 3 reducing their positions, and 10 closing their positions.
633% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 3
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
11% more funds holding
Funds holding: 45 → 50 (+5)
38% less capital invested
Capital invested by funds: $62.9M → $38.9M (-$24M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$6.78M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$3.47M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$694K |
| 4 |
Renaissance Technologies
New York
|
+$678K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$507K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$11.3M |
| 2 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$3.58M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.71M |
| 4 |
DM
Deerfield Management
New York
|
-$1.45M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$1.43M |
KIN Hedge Fund Activity: Q4 2015 in Review
50 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q4 2015, worth a combined $38.9M — down 38% from $62.9M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new KIN positions and 10 closed out — a net gain of 5 holders — while 22 added to existing stakes and 3 trimmed.
The largest buyer was Park West Asset Management, adding an estimated $6.78M. The largest seller was Jennison Associates, exiting entirely with an estimated $11.3M sold.
- 50 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q4 2015, up from 45 in Q3 2015.
- Funds reported $38.9M of Kindred Biosciences, Inc. stock for Q4 2015, down 38% quarter-over-quarter.
- 15 funds opened new Kindred Biosciences, Inc. positions in Q4 2015 and 10 closed out, a net change of +5 holders.
- The largest Kindred Biosciences, Inc. buyer in Q4 2015 was Park West Asset Management, an estimated $6.78M added.
- The largest Kindred Biosciences, Inc. seller in Q4 2015 was Jennison Associates, an estimated $11.3M sold.
Based on aggregated 13F filings for Q4 2015.